CN117210362A - Carbendazim degrading bacteria and degrading enzyme and application thereof - Google Patents
Carbendazim degrading bacteria and degrading enzyme and application thereof Download PDFInfo
- Publication number
- CN117210362A CN117210362A CN202311174985.5A CN202311174985A CN117210362A CN 117210362 A CN117210362 A CN 117210362A CN 202311174985 A CN202311174985 A CN 202311174985A CN 117210362 A CN117210362 A CN 117210362A
- Authority
- CN
- China
- Prior art keywords
- carbendazim
- degrading
- protein
- djl
- bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 title claims abstract description 82
- 239000006013 carbendazim Substances 0.000 title claims abstract description 82
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 title claims abstract description 81
- 230000000593 degrading effect Effects 0.000 title claims abstract description 51
- 241000894006 Bacteria Species 0.000 title claims abstract description 18
- 102000004190 Enzymes Human genes 0.000 title claims description 38
- 108090000790 Enzymes Proteins 0.000 title claims description 38
- 239000006228 supernatant Substances 0.000 claims abstract description 15
- 239000002689 soil Substances 0.000 claims abstract description 13
- 241000611870 Pantoea dispersa Species 0.000 claims abstract description 12
- 238000000855 fermentation Methods 0.000 claims abstract description 12
- 230000004151 fermentation Effects 0.000 claims abstract description 12
- 244000005700 microbiome Species 0.000 claims abstract description 7
- 108010009043 arylesterase Proteins 0.000 claims description 17
- 102000028848 arylesterase Human genes 0.000 claims description 17
- 235000012055 fruits and vegetables Nutrition 0.000 claims description 7
- 235000021056 liquid food Nutrition 0.000 claims description 6
- 239000002351 wastewater Substances 0.000 claims description 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract description 22
- 230000001580 bacterial effect Effects 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 5
- 238000004321 preservation Methods 0.000 abstract description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052799 carbon Inorganic materials 0.000 abstract description 4
- 108091005804 Peptidases Proteins 0.000 abstract description 3
- 239000004365 Protease Substances 0.000 abstract description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract description 3
- 238000012216 screening Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 description 37
- 102000004169 proteins and genes Human genes 0.000 description 33
- 235000018102 proteins Nutrition 0.000 description 27
- 238000000746 purification Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 230000015556 catabolic process Effects 0.000 description 13
- 238000006731 degradation reaction Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 238000001042 affinity chromatography Methods 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 239000000499 gel Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000001514 detection method Methods 0.000 description 8
- 238000001962 electrophoresis Methods 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 239000011543 agarose gel Substances 0.000 description 7
- 150000001413 amino acids Chemical group 0.000 description 7
- 239000003292 glue Substances 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 102000004157 Hydrolases Human genes 0.000 description 5
- 108090000604 Hydrolases Proteins 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
- 229910021642 ultra pure water Inorganic materials 0.000 description 5
- 239000012498 ultrapure water Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 108020004465 16S ribosomal RNA Proteins 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000008351 acetate buffer Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 125000003700 epoxy group Chemical group 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000006142 Luria-Bertani Agar Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000003032 molecular docking Methods 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000012474 protein marker Substances 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000005731 Glucose-6-phosphate isomerase Human genes 0.000 description 1
- 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101710203379 Outer membrane porin C Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000983368 Pantoea sp. Species 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 208000020584 Polyploidy Diseases 0.000 description 1
- 108010013381 Porins Proteins 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 101001010582 Pseudomonas fluorescens Arylesterase Proteins 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000006652 catabolic pathway Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 231100000003 human carcinogen Toxicity 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 102000007739 porin activity proteins Human genes 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- PORMUFZNYQJOEI-UHFFFAOYSA-N sumatriptan succinate Chemical compound OC(=O)CCC(O)=O.CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1 PORMUFZNYQJOEI-UHFFFAOYSA-N 0.000 description 1
- 239000004546 suspension concentrate Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000004563 wettable powder Substances 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses a carbendazim degrading bacterium, the strain of which is named Pantoea dispersa DJL-B and is preserved in the Guangdong province microorganism strain collection center, and the preservation number is GDMCC No:62372. the invention belongs to the technical field of environment-friendly biology, and discloses a method for preparing a bacterial strain capable of rapidly degrading carbendazim, which is identified as Pantoea dispersa DJL-B by taking carbendazim as a unique carbon source and screening out a bacterial strain capable of rapidly degrading carbendazim from soil polluted by carbendazim. In addition, the invention also separates a specific protease from the thallus broken liquid or fermentation supernatant of the carbendazim degrading bacteria.
Description
Technical Field
The invention belongs to the technical field of environment-friendly biology, and particularly relates to carbendazim degrading bacteria, degrading enzyme thereof and application thereof.
Background
Carbendazim (Carbenazem) is a broad-spectrum benzimidazole bactericide with molecular formula of C 9 H 9 N 3 O 2 The white fine crystal powder has good heat stability and is commonly used for preventing and treating various fungal diseases of crops such as rice, fruit trees, vegetables and the like. Carbendazim is stable in acidic solutions and can form soluble salts; and slowly disintegrates in alkaline solutions. Carbendazim has low solubility in water, and has higher solubility in organic solvents such as ethyl acetate, acetone, chloroform and the like. It is generally prepared and sold in industry in the form of wettable powder or suspension concentrates and the like.
Due to the large usage amount, high usage frequency, good stability and strong migration capability in environmental media of the carbendazim, the problem that the residue of the carbendazim in many common foods exceeds the standard is caused, and the adverse effects on human health and ecosystems are caused. The research shows that the accumulated residue of carbendazim can interfere the normal hormone level in human and animals, and influence the normal physiological metabolism, endocrine system, immune system and reproductive function of the organism. The world health organization classifies carbendazim as a chemical hazard and as a human carcinogen. Biodegradation is the most main way to remove the organic pesticide residue at present. Therefore, the research on the aspects of the restoration of the soil with the excessive carbendazim, the degradation technology of the carbendazim in fruits and vegetables and the like is very necessary and urgent.
Disclosure of Invention
In order to solve the problems in the prior art, the invention takes carbendazim as the only carbon source, screens out a strain which can rapidly degrade the carbendazim from the contaminated soil of the carbendazim, and is named Pantoea dispersa DJL-B after identification and is preserved in the microorganism strain preservation center of Guangdong province, and the preservation number is GDMCC No:62372. in addition, the invention also separates and obtains a specific protease from the thallus broken liquid or fermentation supernatant of the carbendazim degrading bacteria, adopts an affinity chromatography technology and a flight mass spectrum detection to separate, purify and identify the structure of the protease, and can hydrolyze benzimidazole rings in carbendazim molecules, thereby realizing the degradation of the carbendazim. The carbendazim degrading bacteria Pantoea dispersa DJL-B and the carbendazim degrading enzyme provided by the invention are expected to play an important role in degrading the carbendazim in fruits and vegetables, waste water, polluted soil or liquid foods, and have important significance for protecting the environment and guaranteeing public health safety.
In one aspect, the invention provides a carbendazim degrading bacterium, the strain of which is named Pantoea dispersa DJL-B and is deposited in the Guangdong province microorganism strain collection, and the deposit number is GDMCC No:62372.
in addition, the invention also provides application of the carbendazim degrading bacteria in degrading fruits and vegetables, waste water, polluted soil or liquid food.
In another aspect, the invention provides a carbendazim degrading enzyme, which is separated from a bacterial body broken liquid or fermentation supernatant of the carbendazim degrading bacteria, and belongs to aryl esterase.
Preferably, the amino acid sequence of the carbendazim degrading enzyme is as follows:
MSTFKTKDGVNLYFKDWGKGQPVLFSHGWPLDADMWDSQLNFLAERGYRVIAFDRRGFG
RSDQPWEGYDYDTFADDIHGLIEHLQLDEVTLVGFSMGGGDVSRYIGRYGTAKVKGLVLL
GAVTPIFGKTDDHPEGVESAVFDGIKAGLLKDRAQFIKEFATPFYGTNAGQTVSDGVLTQTL
NIALLASLKGTLDCVTAFSETDFRADIAKVDVPTLVIHGSNDQVVPFEATGKLVHEMIAGSQLKVYENGPHGFAVTHQDQLNADLLAFLQGN, i.e. SEQ ID NO:1.
preferably, the carbendazim degrading enzyme has a theoretical isoelectric point of 4.93.
In addition, the invention also provides application of the carbendazim degrading enzyme in degrading fruits and vegetables, waste water, polluted soil or liquid food.
Compared with the prior art, the invention has the beneficial effects that:
(1) The invention takes carbendazim as the only carbon source, a strain which can rapidly degrade the carbendazim is screened from the contaminated soil of the carbendazim, is identified and named as Pantoea dispersa DJL-B, and is preserved in the microorganism strain preservation center of Guangdong province, and the preservation number is GDMCC No:62372.
(2) The invention uses affinity chromatography technology to separate and purify the carbendazim degrading enzyme from the thallus broken liquid or fermentation supernatant of the carbendazim degrading bacteria Pantoea dispersa DJL-B, and analyzes the amino acid sequence and structure.
(3) The invention also provides application of the carbendazim degrading bacteria Pantoea dispersa DJL-B and the carbendazim degrading enzyme in degrading fruits and vegetables, waste water, polluted soil or liquid food, and has important significance for protecting environment and guaranteeing public health safety.
Drawings
FIG. 1 is a microscopic examination and colony morphology of carbendazim-degrading bacteria Pantoea dispersa DJL-B.
FIG. 2 shows a 16S-conserved sequence similarity analysis of carbendazim-degrading bacteria Pantoea dispersa DJL-B.
FIG. 3 shows the OD value change of different collecting pipes of the affinity chromatographic column eluent.
FIG. 4 shows an HPLC detection chart of the degradation effect of affinity chromatography purification enzyme on carbendazim; wherein A is fermentation supernatant and B is thallus broken liquid.
FIG. 5 is a diagram showing the result of SDS-PAGE gel electrophoresis detection of the separation and purification effects of degrading enzymes; wherein, 1 is thallus broken liquid without column purification, 2 is thallus broken eluent, 3 is protein Marker,4 is fermentation upper cleaning liquid, and 5 is fermentation supernatant without column purification.
FIG. 6 is a schematic diagram of a homology modeling architecture.
FIG. 7 shows a schematic diagram of the secondary structure of the protein Arylesterase.
FIG. 8 shows a graph of activity prediction of the protein Arylesterase; wherein a, catalytic site detection; and b, pocket detection.
FIG. 9 schematic representation of molecular docking of aryl esterase Arylesterase with carbendazim molecules.
Carbendazim degrading bacteria Pantoea dispersa DJL-B were deposited at the microorganism strain collection of Guangdong province at 4/11/2022 under the accession number of GDMCC No:62372, the preservation address is 5 buildings of No. 59 of No. 100 university of Mitrex, guangzhou City, and the preservation time is 2022, 4 and 11 days.
Detailed Description
The invention will be described in further detail with reference to the drawings and examples.
Example 1: gradient culture of carbendazim degrading bacteria, purification and identification of target bacteria
Soil samples were collected from three different areas, 25g each, from the field where the carbendazim was sprayed. Then, each soil sample was dissolved in 225mL of ultrapure water, and left to stand after sufficient shaking, 1mL of the supernatant was taken in a small conical flask, and 9mL of ultrapure water was added for dilution. 300mL of inorganic salt culture medium lacking a carbon source is prepared, and the culture medium is evenly filled into three conical flasks, and under the aseptic condition, carbendazim with different concentrations, namely 0.05g/100mL, 0.25g/100mL and 0.5g/100mL, is respectively added into each conical flask. These concentrations are 1, 5 and 10 times the effective concentration of carbendazim, respectively. The medium of each concentration was poured into four plates, and three soil dilutions, 0.1mL, were added to each of the three plates, and spread evenly. The remaining one plate served as a blank. All plates were incubated in a 28℃incubator and observed for colony growth. Standing the final domestication enrichment culture solution, and sequentially mixing with 10 -1 -10 -6 Concentration gradient dilution of 10 -4 、10 -5 、10 -6 200 mu L of dilution liquid of dilution gradient is coated on a separation and purification culture medium rich in 100mg/L carbendazim, and is cultured for 5d at 30 ℃, and three gradients are arranged in parallel. Colonies with different morphological characteristics are picked, streaked and separated on a separation and purification culture medium (containing 100mg/L carbendazim) and cultured at 30 ℃. This procedure was repeated until the plates appeared single colonies with good growth and stable passage, and then transferred to a medium more suitable for their growth and propagation for storage.
2. Purification of target bacteria
1 bacterial strain which can grow in 50mg/L carbendazim environment and shows high-efficiency degradation capacity is separated in an enrichment culture domestication mode, and is named as DJL-B. The degradation rate of the strain to carbendazim in 4d reaches more than 95.3%. To further identify the characteristics and classification status of the strain, it was transferred to LB agar medium and subjected to purification culture in an incubator at 37 ℃. Since the strain has resistance to carbendazim, 0.5 times of effective concentration (0.025 g/100 mL) of carbendazim is added into the culture medium as selective pressure to prevent mixed bacteria from polluting. After single round transparent colorless or pale yellow single bacterial drop appears on the flat plate, sealing the flat plate by using a sealing film, and transferring the flat plate into a refrigerator at the temperature of 4 ℃ for storage.
3. Identification of target bacteria
In order to identify the morphological characteristics and the classification status of DJL-B, the following experiments were performed. First, the microscopic examination and colony morphology of DJL-B were observed, and the results are shown in FIG. 1. The colony is round, transparent, colorless or pale yellow, has neat edges and soft texture; the cells were rod-shaped with rounded ends and gram-negative. Secondly, extracting the genomic DNA of DJL-B by using the kit, and carrying out PCR amplification of the 16S rRNA gene by using the genomic DNA as a template and using a universal primer 27F/1492R, wherein the 16S rDNA sequence of the DJL-B is as follows:
CGCCAATGCGGAGCTACACATGCAAGTCGAACGGCAGCACAGAAGAGCTTGCTCTTTG
GGTGGCGAGTGGCGGACGGGTGAGTAATGTCTGGGAAACTGCCCGATGGAGGGGGATA
ACTACTGGAAACGGTAGCTAATACCGCATAACGTCGCGAGACCAAAGTGGGGGACCTTC
GGGCCTCACACCATCGGATGTGCCCAGATGGGATTAGCTAGTAGGTGGGGTAATGGCTC
ACCTAGGCGACGATCCCTAGCTGGTCTGAGAGGATGACCAGCCACACTGGAACTGAGA
CACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGC
CTGATGCAGCCATGCCGCGTGTATGAAGAAGGCCTTCGGGTTGTAAAGTACTTTCAGCG
GGGAGGAAGGCGGTGAGGTTAATAACCTTGCCGATTGACGTTACCCGCAGAAGAAGCA
CCGGCTAACTCCGTGCCAGCAGCCGCGGTAATACGGAGGGTGCAAGCGTTAATCGGAAT
TACTGGGCGTAAAGCGCACGCAGGCGGTCTGTTAAGTCAGATGTGAAATCCCCGGGCTT
AACCTGGGAACTGCATTTGAAACTGGCAGGCTTGAGTCTCGTAGAGGGGGGTAGAATTC
CAGGTGTAGCGGTGAAATGCGTAGAGATCTGGAGGAATACCGGTGGCGAAGGCGGCCC
CCTGGACGAAGACTGACGCTCAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATAC
CCTGGTAGTCCACGCCGTAAACGATGTCGACTTGGAGGTTGTGCCCTTGAGGCGTGGCT
TCCGGAGCTAACGCGTTAAGTCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTC
AAATGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGATGCAACG
CGAAGAACCTTACCTGGCCTTGACATCCAGAGAACTTAGCAGAGATGCTTTGGTGCCTT
CGGGAACTCTGAGACAGTGCTGCATGGCTGTCGTCAGCTCGTGTGTGAAATGTGGGTTA
GTCCCGCACGAGCGCAACCCTTATCCTTTGTTGCCAGCGGCTCGGCCGGGAACTCAAAGGAGACTGCCGGGTGATA, i.e. SEQ ID NO:2. the amplified product was obtained by agarose gel electrophoresis analysis and had a size of about 1.5 kb. Then, the PCR product of the 16S rRNA gene was ligated with pGM-T vector to transform E.coli DH 5. Alpha. And positive clones were selected on LB agar medium containing ampicillin. The purpose of this is to improve the accuracy and reliability of the sequencing results. Positive clones were sequenced bi-directionally and the sequencing results were aligned homology to the nucleotide sequences registered in GenBank using Blast on NCBI website. Through comparison analysis, DJL-B (GenBank accession number OM 943751) was found to belong to Pantoea sp. To further confirm the phylogenetic relationship between this strain and other related strains, a corresponding appropriate amount of model strain was selected, and a phylogenetic evolutionary tree was established using the proximity method (based on similarity of 16S rRNA sequences), as shown in fig. 2. The strain has been deposited in the Guangdong province microorganism bacterial culture Collection (GDCCC) under the accession number 62372.
Example 2: separation and purification of carbendazim degrading enzyme
1. Preparation of carbendazim-agarose gel CL-4B chromatographic column
1.1 activation: accurately weighing 1.0g of agarose gel medium, sequentially adding 20-30mL of a 50%,70% dimethyl sulfoxide aqueous solution into the medium, sequentially stirring and cleaning for 5min, vacuum-pumping and filtering out cleaning liquid after each cleaning, adding epichlorohydrin, dimethyl sulfoxide and 5mL of 5mol/L sodium hydroxide solution with the volume ratio of 1.5:1 into the medium after gradient washing to prepare suspension, and placing the suspension into a constant-temperature oscillating box at 44 ℃ for oscillating reaction for 4h at 150 rpm. After the reaction was completed, the reaction mixture was poured into a sand core funnel and washed with 20 volumes of deionized water until no epoxy groups were detected in the eluate (epoxy groups were detected by sodium thiosulfate titration).
1.2 coupling: the activated agarose gel CL-4B is weighed and suspended in acetate buffer (pH 6.0) containing a certain concentration of carbendazim ligand (the coupling amount is generally 10-30mg ligand per g carrier), the coupling reaction is carried out for 20 hours at 37 ℃ and 110rpm, free ligand is removed by using a polyploid volume of deionized water, the solution is transferred into 1mol/L ethanolamine solution, and the solution is subjected to shaking incubation for 6 hours at 37 ℃ to remove residual active epoxy groups. After the reaction is completed, washing with a large amount of deionized water, filling the prepared affinity adsorbent into a chromatographic column, naturally settling, washing 10-20 column bed volumes with 1 x Phosphate Buffer Solution (PBS), soaking in 20% ethanol, and storing at 4 ℃ for later use.
2. Separation and purification of carbendazim degrading enzyme
2.1, taking bacterial liquid after activation culture, centrifuging at 4000rpm for 15min at 4 ℃, respectively recovering supernatant and precipitated bacterial bodies, and passing the supernatant through a microporous filter membrane with the thickness of 0.45 mu m to obtain extracellular crude enzyme liquid for later use. The bacteria were resuspended in bacterial protein preparation lysate (containing 0.2mmol/L trypsin inhibitor PMSF) and sonicated (power 400W,2 s/time, interval 6s, time 15 min) under ice bath conditions. After the completion of the ultrasonic treatment, the mixture is centrifuged for 20min at 12000rpm and 4 ℃, and the supernatant is collected, thus obtaining the intracellular crude enzyme liquid.
2.2 the coupled carbendazim-agarose gel CL-4B medium was loaded onto a chromatography column and the column was equilibrated with 1 XPhosphate buffer (PBS). Affinity chromatography: and loading the crude enzyme liquid into an affinity chromatography column, and controlling the outflow speed of the crude enzyme liquid to be not more than 1mL/min. Washing: after the crude enzyme solution is completely discharged, the crude enzyme solution is used as a washing impurity solution to be passed through a column to remove impurities, and the light absorption of the effluent liquid at the wavelength of 280nm is achievedAfter the degree value stabilized at baseline, the 1 XPBS buffer wash was stopped. Eluting: eluting the target protein with acetate buffer solution (containing 0.5mol/L NaCl) at pH4.0 and 0.1mol/L, and immediately collecting the effluent until OD 280 The value was reduced to 0.00. And (3) dialysis: all the effluent was collected with a 1000D dialysis bag and dialyzed in ultrapure water for 20 hours to remove residual ions. Concentrating: concentrating the target protein liquid by adopting a freeze-drying mode to obtain the carbendazim degrading enzyme with higher concentration and purity. And (3) re-dissolving a proper amount of freeze-dried enzyme powder in ultrapure water for activity detection, and performing SDS-PAGE electrophoresis on the active components.
2.3 after passing the two crude enzyme solutions through the affinity chromatography column, the column was washed with 1 XPBS buffer to wash off the heteroproteins. Effluent OD of column to be affinity 280 Values stabilized at baseline, indicating that the hybrid protein had been cleared. After passing through the column with 0.1mol/L acetate buffer (containing 0.5mol/L NaCl), the degrading enzyme combined with carbendazim molecule can be separated out and become free again and eluted due to the change of pH value in the column environment. As shown in fig. 3, at the beginning of elution, almost no protein was detected as the eluent did not completely infiltrate the affinity column; after 4 tubes were collected, the protein content of the eluate increased sharply. Therefore, the protein is eluted by the buffer solution with higher ionic strength, and the aim of fast eluting once and obtaining very concentrated protein peaks in a smaller eluting volume can be achieved.
2.4 analysis of the degradation Effect of affinity chromatography purified protein on carbendazim
In order to confirm that the protein purified by the carbendazim-agarose gel CL-4B affinity chromatography column is indeed a degrading enzyme acting on carbendazim, 200. Mu.L of the purified enzyme was placed in 5mL of Tris-HCl buffer pH7.2 and mixed uniformly, and the mixture was subjected to high performance liquid chromatography HPLC at 30℃for 4 hours. By comparing the negative control group with the treatment group treated by the degrading enzyme, the protein purified by the affinity chromatography is found to have a degradation effect on carbendazim, and the degradation effect of the thallus breaking liquid is obviously better than that of the fermentation supernatant, and the degradation rate reaches 44.7 percent, as shown in figure 4.
2.5SDS-PAGE gel electrophoresis detection of degrading enzyme separation and purification effect
2.5.1 glue preparation: 10% split gum and 5% concentrated gum were prepared. Two glass plates which are washed and dried in advance are aligned and fixed on a glue making frame, ultra-pure water is added into a gap and placed for a period of time to check the air tightness. Slowly pumping the pre-mixed separating gel along two glass gaps by using a pipetting gun, and standing for gel 30min in a 37 ℃ incubator after the gel surface rises to the middle height of the green sheets of the gel making frame. When a clear parting line appears between the water and the lower glue, indicating that the glue has polymerized and coagulated, pouring the upper water and sucking the water dry with filter paper, immediately inserting a sample comb after filling with concentrated glue, waiting for polymerization for 30min. Finally, the electrophoresis system was assembled, and after 1 XTris-glycine running buffer was added to the inside glass plate, the sample comb was carefully pulled out to prevent the generation of bubbles.
2.5.2 loading: according to the proportion of 4 mu L and 1 mu L, the protein sample liquid to be tested and 5 multiplied by protein loading buffer are mixed in an EP tube, and the mixture is placed in a constant temperature metal bath at 100 ℃ for heating for 8min to denature protein, and the mixture is subjected to micro-speed centrifugation. 12. Mu.L of the supernatant was aspirated with a microsyringe and added to each lane in sequence, and 4. Mu.L of protein Marker was added to the reserved lane as a reference.
2.5.3 electrophoresis: electrophoresis parameter setting: firstly, concentrating the gel at 80V and running for 17min; the gel was separated at 100V and run for 1.5h until the bromophenol blue indicator migrates near the bottom of the gel surface and the electrophoresis was terminated.
2.5.4 staining: after electrophoresis, the glass plate is removed, the film is gently peeled off and placed in a large petri dish with a diameter of 150mm, and a proper amount of 0.25% coomassie brilliant blue R-250 dye solution is injected for dyeing for 2.5 hours, and if necessary, overnight.
2.5.5 decoloring: the dyeing liquid is discarded, the glue surface is rinsed for several times by distilled water, the decoloring liquid is added until the glue surface is completely soaked, and finally, diffusion decoloring is carried out on a decoloring shaking table, and the decoloring liquid is replaced every 25 minutes until the protein strips are clearly visible.
2.5.6 gel image acquisition. The two enzyme solutions are subjected to carbendazim-agarose gel CL-4B affinity chromatography, dialysis and concentration, and then the separation and purification effects of degrading enzymes are detected by SDS-PAGE gel electrophoresis, as shown in figure 5. Lanes 1 and 5 show the cell disruption solution and fermentation supernatant, respectively, without column purification. As a result of electrophoresis, the strain DJL-B produced various enzymes, and the molecular weight was substantially 100kDa or less. Lanes 2 and 4 show the cell disruption eluate and the wash solution on fermentation, respectively. It can be found that the thallus broken liquid and the fermentation supernatant after column purification have bands at two identical positions (about 30kDa and 40 kDa) of the film, the protein bands of the thallus broken eluent are more abundant, and the target protein and other proteins are possibly interacted and combined together in the process of column passing affinity for simultaneous elution; secondly, the presence of hybrid proteins is possible. The analysis of the degradation effect of the purified enzyme can be combined, and the self-made carbendazim-agarose gel CL-4B affinity chromatographic column of the research has higher specific binding property, so that the protein with degradation effect on carbendazim can be effectively purified.
Example 3: identification of carbendazim degrading enzyme
3.1 Mass Spectrometry characterization
After SDS-PAGE electrophoresis and comparative analysis, the enzyme solution is selected to cut three distinct gel blocks with the molecular weight of about 60kDa, 40kDa and 30kDa (see box label in FIG. 5), and protein mass spectrometry is performed by MALDI-TOF-MS. The protein bands can be subjected to enzymolysis analysis to obtain peptide sequences, and sequence comparison is carried out in NCBI, uniProt and other databases, and analysis results show that the theoretical molecular weight (Mass) of three target bands is consistent with that of SDS-PAGE gel electrophoresis, wherein the protein A0A6A5BA66 is named as Arylesterase, the similarity of the peptide sequences and Alpha/beta hydrolase foldprotein is 95%, and the protein is Alpha/beta hydrolase; the A0A437T546 protein is named as Porin OmpC, the similarity of the peptide fragment sequence and the Membrane protein is 100%, and the protein is Porin; the peptide sequence of A0A6A5B7B7 has 90 percent of similarity with Glucose-6-phosphate isomerase, and is an isomerase. The currently accepted classical degradation pathway of carbendazim is that the alpha/beta hydrolase encoded by the gene MheI is responsible for the first degradation of carbendazim, which exerts the hydrolytic action of deamidating groups. The Arylesterase and the homonymous carbendazim hydrolase MheI encoded by the gene MheI are both catalytically active and belong to the alpha/beta hydrolase superfamily. From the above results, it is found that the carbendazim degrading enzyme Arylesterase plays an important role in the degradation of carbendazim.
3.2 analysis of primary Structure of protein
The primary structure and related physicochemical characteristics of the carbendazim degrading enzyme Arylesterase were evaluated using a ExPASy ProtParam Server (http:// web. Expasy. Org/protparam /) network database system. The results show that the theoretical isoelectric point of the Arylesterase is 4.93, the Arylesterase has 273 amino acids in total, the sequence only contains 1 cysteine Cys, the disulfide bond formation possibility does not exist, and the Instability Index (II) is calculated to be 16.89 and is classified into a stable category. The protein FASTA sequence is as follows: MSTFKTKDGVNLYFKDWGKGQPVLFSHGWPLDADMWDSQLNFLAERGYRVIAFDRRGFGRSDQPWEGYDYDTFADDIHGLIEHLQLDEVTLVGFSMGGGDVSRYIGRYGTAKVKGLVLLGAVTPIFGKTDDHPEGVESAVFDGIKAGLLKDRAQFIKEFATPFYGTNAGQTVSDGVLTQTLNIALLASLKGTLDCVTAFSETDFRADIAKVDVPTLVIHGSNDQVVPFEATGKLVHEMIAGSQLKVYENGPHGFAVTHQDQLNADLLAFLQGN, i.e. SEQ ID NO:1.
3.3 Secondary Structure of proteins and homology modeling analysis
Template search was performed on the protein sequence by SWISS-MODEL (http:// swissmodel. Expasy. Org /) on-line server, and the amino acid sequence similarity of Arylesterase and Pseudomonas fluorescens aryl esterase (PDB number: 3 HEA) derived from Pseudomonas fluorescens was found to be the highest and 72.32%. It is reported that the similarity between the amino acid sequence and the template exceeds 30%, so that the reliability of the model obtained by homologous modeling is high. Thus, the amino acid sequence of Arylesterase was introduced into Phyre 2 (Protein Fold Recognition Server) in-line software, 3D modeling of protein sequences was performed using a method of remote homology detection. The homology modeling structure is shown in FIG. 6, indicating that 99% of the amino acids are modeled with a confidence level of greater than 90% (resolution) The protein model is reasonable to construct, achieves the experimental verification level of the protein structure, and can be used for subsequent protein transformation or related research. At the same time via Phyre 2 It was found that the secondary structure of the protein Arylesterase containedThere was 45% alpha helix, 17% beta sheet and 6% transmembrane helix as shown in figure 7.
3.4 discussion of mechanism of action
By Phyre 2 The three-stage structure model of the protein Arylesterase is deeply analyzed on line to obtain a predicted catalytic active site, and a large pocket is found at the position of the corresponding active site and is a reactive center, as shown in FIG. 8. The carbendazim structural formula was constructed using ChemDraw software and optimized using classical MM3 force field and semi-empirical PM6 force field to ensure that the molecules exist in the best active form. Molecular docking analysis was then performed on aryl esterase Arylesterase and carbendazim molecules using Autodock-Vina, and the results are shown in FIG. 9. The carbendazim molecule is located exactly in the active cavity of the aryl esterase and the affinity between the two is-5.6 kcal/mol, a smaller value indicating that the structure is more stable, indicating that this binding is advantageous.
The foregoing is a further detailed description of the invention in connection with the preferred embodiments, and it is not intended that the invention be limited to the specific embodiments described. It will be apparent to those skilled in the art that several simple deductions or substitutions may be made without departing from the spirit of the invention, and these should be considered to be within the scope of the invention.
Claims (6)
1. The carbendazim degrading bacteria are characterized in that: the strain is named Pantoea dispersa DJL-B and is deposited in the Guangdong province microorganism strain collection center, and the deposit number is GDMCC No:62372.
2. the use of the carbendazim degrading bacteria according to claim 1 for degrading carbendazim in fruits and vegetables, waste water, contaminated soil or liquid food.
3. A carbendazim degrading enzyme, characterized in that: a cell disruption solution or fermentation supernatant isolated from the carbendazim degrading bacterium of claim 1, which is an aryl esterase.
4. The carbendazim degrading enzyme according to claim 2, wherein: the amino acid sequence is as follows:
MSTFKTKDGVNLYFKDWGKGQPVLFSHGWPLDADMWDSQLNFLAERGYRVIAFDRRGFGRSDQPWEGYDYDTFADDIHGLIEHLQLDEVTLVGFSMGGGDVSRYIGRYGTAKVKGLVLLGAVTPIFGKTDDHPEGVESAVFDGIKAGLLKDRAQFIKEFATPFYGTNAGQTVSDGVLTQTLNIALLASLKGTLDCVTAFSETDFRADIAKVDVPTLVIHGSNDQVVPFEATGKLVHEMIAGSQLKVYENGPHGFAVTHQDQLNADLLAFLQGN, i.e. SEQ ID NO:1.
5. a carbendazim degrading enzyme according to claim 3, wherein: its theoretical isoelectric point is 4.93.
6. Use of a carbendazim degrading enzyme according to any one of claims 3 to 5 for degrading carbendazim in fruits and vegetables, waste water, contaminated soil or liquid food.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311174985.5A CN117210362A (en) | 2023-09-13 | 2023-09-13 | Carbendazim degrading bacteria and degrading enzyme and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311174985.5A CN117210362A (en) | 2023-09-13 | 2023-09-13 | Carbendazim degrading bacteria and degrading enzyme and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117210362A true CN117210362A (en) | 2023-12-12 |
Family
ID=89040075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311174985.5A Pending CN117210362A (en) | 2023-09-13 | 2023-09-13 | Carbendazim degrading bacteria and degrading enzyme and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117210362A (en) |
-
2023
- 2023-09-13 CN CN202311174985.5A patent/CN117210362A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109280656B (en) | Recombinant beauveria bassiana proteinase K mutant PK-M1 and preparation method thereof | |
CN111808765B (en) | Bacillus subtilis capable of efficiently degrading vomitoxin and application thereof | |
CN111961617A (en) | Multi-effect bacillus subtilis for high yield of immune polysaccharide and bacteriocin and application thereof | |
Gmeiner | The isolation of two different lipopolysaccharide fractions from various Proteus mirabilis strains | |
KR102186997B1 (en) | Novel method of protein purification | |
CN108794635A (en) | A kind of Bovine lactoferricin-human lysozyme fusion protein, gene and its application | |
CN110951814B (en) | Method for preparing prostaglandin E1 by using genetically engineered cyclooxygenase-1 and genetically engineered prostaglandin E synthetase-1 | |
CN111285925A (en) | Separation and purification method of lactobacillus paracasei ZFM54 bacteriocin | |
CN108070605B (en) | Carbendazim degrading enzyme CbmA as well as coding gene and application thereof | |
CN116333957A (en) | Recombinant bacillus for displaying streptococcus suis prophage lyase, construction method and application thereof | |
CN102703457A (en) | Method for preparing and expressing antibacterial peptide gene | |
CN113142214B (en) | Application of antibacterial protein of bacillus methylotrophicus wswGH-10 and separation and purification method | |
EP0477285B1 (en) | Processes for the recovery of microbially produced chymosin | |
CN109207460B (en) | Recombinant beauveria bassiana proteinase K mutant PK-M2 and preparation method thereof | |
CN109929778A (en) | A kind of efficient flavored type bacterial strain and its application in raising cigarette quality | |
CN117210362A (en) | Carbendazim degrading bacteria and degrading enzyme and application thereof | |
CN106243205B (en) | A kind of albumen of clavacin of degrading and its encoding gene and application | |
CN101773522B (en) | Animal intestinal mucosa extract and preparation method as well as application thereof | |
CN113956995B (en) | Thiophanate-methyl degrading bacterium, thiophanate-methyl degrading enzyme and immobilized enzyme thereof | |
CN100417725C (en) | Adsorption and separation of collagen fiber supported metal ion adsorption material to microorganism and protein | |
CN107267547A (en) | Novel antimicrobial peptide DLP2 preparation method | |
CN109265553B (en) | Fusion protein of cytoglobin and sipunculus nudus plasmin | |
CN113862277B (en) | Preparation method and application of garrupa antibacterial peptide NK-Lysin mature peptide recombinant protein | |
CN102212547A (en) | Intestinal trefoil factor recombinant expression vector and preparation method of intestinal trefoil factor | |
CN107245369B (en) | Method for producing vegetable oil without zearalenone by biological enzyme method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |